Digital health platforms attracting non-health investors Ukraine’s largest telecom operator Kyivstar is investing $160 million to expand into online medicine through a major digital healthcare platform handling millions of bookings […]

With new approvals and research advances, immunotherapy combinations are increasingly being used in gynecologic cancers instead of traditional monotherapy approaches. Why it matters: Oncology is shifting from organ-based treatment → […]

Hospitals globally are being pushed to redesign infrastructure, energy systems, and supply chains to reduce carbon emissions while maintaining patient safety standards. 💡 Insight: Healthcare contributes nearly the same emissions […]

India’s drug regulator CDSCO is working on accelerated approval pathways for critical and innovative medicines to improve patient access and strengthen the country’s global pharma competitiveness. The move is aimed […]

India has begun Phase-1 human trialsof a locally developed vaccine for Kyasanur Forest Disease (a deadly tick-borne viral infection affecting Western Ghats regions). (The Times of India) Why this matters: […]

AstraZeneca’s Durvalumab immunotherapy approved in India for gastric cancers. 👉 Why this matters India’s oncology market is rapidly moving toward immunotherapy-based protocols — hospitals must prepare: infusion infra molecular diagnostics […]

Hyderabad, 06/02/2026: Yashoda Hospitals, Somajiguda, has successfully treated a 10-month-old male child diagnosed with Congenital Amegakaryocytic Thrombocytopenia (CAMT), a rare inherited bone marrow failure disorder marked by severe thrombocytopenia and […]

India announced a ₹10,000 crore Biopharma Shaktiprogram to push biologics, R&D and advanced drug manufacturing — not just generics anymore. (BW Healthcare World) At the same time, government leaders highlighted […]